Tor Audun Hervig

Emeritus

Department of Clinical Science

E-mailtor.hervig@uib.no
Visitor Address
Haukeland universitetssykehus, Laboratoriebygget

5009 Bergen
Postal Address
Postboks 7804

5020 Bergen

Publications

Academic article

Show author(s) (2023). Training of medical students in the use of emergency whole blood collection and transfusion in the framework of a civilian walking blood. Transfusion. S60-S66.
Show author(s) (2023). Evidensbasert transfusjonspraksis ved jernmangelanemi. Tidsskrift for Den norske legeforening.
Show author(s) (2023). Covid-19-pasienter behandlet med rekonvalesensplasma. Tidsskrift for Den norske legeforening.
Show author(s) (2023). Convalescent plasma from Norwegian blood donors to treat COVID-19. Tidsskrift for Den norske legeforening.

Show author(s) (2022). In vitro quality and hemostatic function of cold-stored CPDA-1 whole blood after repeated transient exposure to 28°C storage temperature. Transfusion. S105-S113.
Show author(s) (2022). Carbamylation of integrin αIIbβ3: The mechanistic link to platelet dysfunction in ESKD. Journal of the American Society of Nephrology. 1841-1856.

Show author(s) (2021). Spontaneous Splenic Artery Rupture as the First Symptom of Systemic Amyloidosis. Case Reports in Critical Care.
Show author(s) (2021). Prehospital Whole Blood Transfusion Programs in Norway. Transfusion Medicine and Hemotherapy. 324-330.
Show author(s) (2021). Platelet microparticles protect acute myelogenous leukemia cells against daunorubicin-induced apoptosis. Cancers. 1-17.
Show author(s) (2021). Platelet microparticles decrease daunorubicin‐induced dna damage and modulate intrinsic apoptosis in thp‐1 cells. International Journal of Molecular Sciences. 1-16.
Show author(s) (2021). Pasientar og blodgivarar med hemokromatose:ei spørjeundersøking ved Helse Førde. Bioingeniøren. 28-32.
Show author(s) (2021). In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature. Transfusion. S101-S110.
Show author(s) (2021). Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies. American Journal of Hematology.
Show author(s) (2021). Effect of leukoreduction and temperature on risk of bacterial growth in CPDA-1 whole blood: A study of Escherichia coli. Transfusion. S80-S89.
Show author(s) (2021). A whole blood based resuscitation strategy in civilian medical services: Experience from a Norwegian hospital in the period 2017–2020. Transfusion. S22-S31.

Show author(s) (2020). Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering. Stem Cell Research & Therapy. 1-18.
Show author(s) (2020). Environmental pollutants in blood donors: The multicentre Norwegian donor study. Transfusion Medicine. 1-9.
Show author(s) (2020). Cold-stored whole blood in a Norwegian emergency helicopter service: an observational study on storage conditions and product quality. Transfusion. 1544-1551.
Show author(s) (2020). Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties. Transfusion. 1042-1049.
Show author(s) (2020). A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery. Anesthesiology. 1173-1183.

Show author(s) (2019). Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies. Blood Transfusion. 181-190.
Show author(s) (2019). In vitro quality and platelet function of cold and delayed cold storage of apheresis platelet concentrates in platelet additive solution for 21 days. Transfusion. 2652-2661.
Show author(s) (2019). How do I get an emergency civilian walking blood bank running? Transfusion. 1446-1452.

Show author(s) (2018). The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis. Cytotherapy. 740-754.
Show author(s) (2018). RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital. Transfusion Medicine. 1-10.
Show author(s) (2018). Preparation of leukoreduced whole blood for transfusion in austere environments; effects of forced filtration, storage agitation, and high temperatures on hemostatic function. Journal of Trauma and Acute Care Surgery. S93-S103.
Show author(s) (2018). Massive transfusion: changing practice in a single Norwegian centre 2002?2015. Transfusion Medicine. 357-362.
Show author(s) (2018). Immediate effects of blood donation on physical and cognitive performance-A randomized controlled double-blinded trial. Journal of Trauma and Acute Care Surgery. S125-S131.
Show author(s) (2018). Hemostatic efficacy of pathogen-inactivated vs untreated platelets: A randomized controlled trial. Blood. 223-231.
Show author(s) (2018). Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases. Vox Sanguinis. 657-668.

Show author(s) (2017). Thromboelastography may predict risk of grade 2 bleeding in thrombocytopenic patients. Vox Sanguinis. 578-585.
Show author(s) (2017). Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres. Vox Sanguinis. 9-17.
Show author(s) (2017). A prospective observational study on effects of fever on red cell transfusion outcome. Vox Sanguinis. 484-486.

Show author(s) (2016). The Simons Genome Diversity Project: 300 genomes from 142 diverse populations. Nature. 201-206.
Show author(s) (2016). Survival after ultramassive transfusion: A review of 1360 cases. Transfusion. 558-563.
Show author(s) (2016). Making whole blood available in austere medical environments: Donor performance and safety. Transfusion. S166-S172.
Show author(s) (2016). Intraoperative transfusion practices in Europe. British Journal of Anaesthesia. 255-261viii.
Show author(s) (2016). Immunomodulation induced by stem cell mobilization and harvesting in healthy donors: Increased systemic osteopontin levels after treatment with granulocyte colony-stimulating factor. International Journal of Molecular Sciences.
Show author(s) (2016). A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: The Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial. BMJ Open.

Show author(s) (2015). The role of recent admixture in forming the contemporary West Eurasian genomic landscape. Current Biology. 2518-2526.
Show author(s) (2015). The lost art of whole blood transfusion in austere environments. Current sports medicine reports. 129-134.
Show author(s) (2015). Low frequency of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. British Journal of Haematology. 598-603.
Show author(s) (2015). Global diversity, population stratification, and selection of human copy-number variation. Science.
Show author(s) (2015). Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation. Journal of Trauma and Acute Care Surgery. S26-S30.
Show author(s) (2015). Coagulation function of stored whole blood is preserved for 14 days in austere conditions: A ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. Journal of Trauma and Acute Care Surgery. S31-S38.
Show author(s) (2015). A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment. Vox Sanguinis. 343-352.

Show author(s) (2014). Whole blood: The future of traumatic hemorrhagic shock resuscitation. Shock. 62-69.
Show author(s) (2014). Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: Definitions, current practice, and knowledge gaps. Shock. 3-12.
Show author(s) (2014). Refrigerated platelets for the treatment of acute bleeding: A review of the literature and reexamination of current standards. Shock. 51-53.
Show author(s) (2014). Prehospital use of plasma: The blood bankers' perspective. Shock. 39-43.
Show author(s) (2014). Norwegian red cross - 80 years in service for blood donors. Transfusion and Apheresis Science. 136-138.
Show author(s) (2014). Low titer group o whole blood in emergency situations. Shock. 70-75.
Show author(s) (2014). Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis. Blood Transfusion. s84-s89.
Show author(s) (2014). Emergency whole-blood use in the field: A simplified protocol for collection and transfusion. Shock. 76-83.
Show author(s) (2014). Comparison of in vitro responses to fresh whole blood and reconstituted whole blood after collagen stimulation. Blood Transfusion. 50-55.
Show author(s) (2014). Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients . Transfusion and Apheresis Science. 97-102.
Show author(s) (2014). Ancient human genomes suggest three ancestral populations for present-day Europeans. Nature. 409-413.

Show author(s) (2013). Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 850-860.
Show author(s) (2013). Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfusion Medicine. 397-406.
Show author(s) (2013). Donor performance of combat readiness skills of special forces soldiers are maintained immediately after whole blood donation A study to support the development of a prehospital fresh whole blood transfusion program. Transfusion. 526-530.
Show author(s) (2013). Blood doping: The flip side of transfusion and transfusion alternatives. Transfusion and Apheresis Science. 90-94.
Show author(s) (2013). Blood Far Forward-a whole blood research and training program for austere environments. Transfusion. 124S-130S.
Show author(s) (2013). Anemia treatment of lymphoproliferative malignancies with erypoiesis: An overview of state of the art. Transfusion and Apheresis Science. 277-281.

Show author(s) (2012). The peopling of Europe and the cautionary tale of Y chromosome lineage R-M269. Proceedings of the Royal Society of London. Biological Sciences. 884-892.
Show author(s) (2012). The effects of selective serotonin reuptake inhibitors on platelet function in whole blood and platelet concentrates. Platelets. 299-308.
Show author(s) (2012). Symposium on fresh whole blood for severe hemorrhagic shock: From in-hospital to far forward resuscitations. Transfusion and Apheresis Science. 113-117.
Show author(s) (2012). Military walking blood bank and the civilian blood service. Transfusion and Apheresis Science. 341-342.
Show author(s) (2012). Challenges and opportunities to prevent transfusion errors: a Qualitative Evaluation for Safer Transfusion (QUEST). Transfusion. 1687-1695.

Show author(s) (2011). Serum Folate Is Significantly Correlated with Plasma Cysteine Concentrations in Healthy Industry Workers. Annals of Nutrition and Metabolism. 68-73.
Show author(s) (2011). Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts? Cytotherapy. 1013-1024.
Show author(s) (2011). Evaluation of noninvasive methods for the estimation of haemoglobin content in red blood cell concentrates. Transfusion Medicine. 145-149.
Show author(s) (2011). Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 1259-1268.
Show author(s) (2011). Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates. Transfusion and Apheresis Science. 75-84.
Show author(s) (2011). A prospective observational study of the effect of platelet transfusions on levels of platelet-derived cytokines, chemokines and interleukins in acute leukaemia patients with severe chemotherapy-induced cytopenia. European Cytokine Network. 52-62.

Show author(s) (2010). Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion. 766-775.
Show author(s) (2010). The Mirasol (R) Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution. Blood Transfusion. 186-192.
Show author(s) (2010). Self-treatment of an ABO-incompatible blood transfusion. Transfusion and Apheresis Science. 215-216.
Show author(s) (2010). Pathogen inactivation of platelet concentrates. Vox Sanguinis. 85-95.
Show author(s) (2010). Monitoring and treatment of anti-D in pregnancy. Vox Sanguinis. 177-192.
Show author(s) (2010). Minor diurnal and activity-induced variations in daytime peripheral blood platelet counts do not have any major impact on platelet yield by platelet apheresis. Transfusion and Apheresis Science. 33-36.
Show author(s) (2010). Effekten av blodgivningsfrekvens på jernstatus. Bioingeniøren. 6-10.
Show author(s) (2010). Effect of iron supplementation on iron status during the first week after blood donation. Vox Sanguinis. e249-e256.
Show author(s) (2010). Blood donors with hereditary hemochromatosis. Transfusion. 1787-1793.
Show author(s) (2010). A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. Vox Sanguinis. 71-76.

Show author(s) (2009). Thrombelastography. Transfusion and Apheresis Science. 119-123.
Show author(s) (2009). Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion.
Show author(s) (2009). The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
Show author(s) (2009). The effect of blood donation frequency on iron status. Transfusion and Apheresis Science. 165-169.
Show author(s) (2009). Left ventricular long-axis function in treated haemochromatosis. The International Journal of Cardiac Imaging. 237-247.
Show author(s) (2009). Left ventricular diastolic function in patients with treated haemochromatosis. Scandinavian Cardiovascular Journal. 32-38.
Show author(s) (2009). Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
Show author(s) (2009). Iron status in Norwegian blood donors: comparison of iron status in new blood donors registered in 1993-1997 and in 2005-2006. Vox Sanguinis. 49-55.
Show author(s) (2009). Immunization in pregnancy. Tidsskrift for Den norske legeforening. 2016-2018.
Show author(s) (2009). Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors. Transfusion. 2359-2365.
Show author(s) (2009). Connexins Are Active Participants of Hematopoietic Stem Cell Regulation. Stem Cells and Development. 807-812.
Show author(s) (2009). A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 1564-1573.

Show author(s) (2008). Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 155-159.
Show author(s) (2008). Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro. Platelets. 55-159.

Show author(s) (2007). Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation. 470-475.
Show author(s) (2007). In vitro evaluation of platelet concentrates during storage: platelet counts and markers of platelet destruction. Transfusion and Apheresis Science. 261-268.
Show author(s) (2007). In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion. 653-665.

Show author(s) (2006). Evaluation of a porcine model to study in vivo platelet activation. Thrombosis Research. 341-352.

Show author(s) (2005). Large-volume leukapheresis yields more viable CD34+cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+cells. Transfusion. 248-253.

Show author(s) (2004). The platelet count accuracy of platelet concentrates obtained by using automated analysis is influenced by instrument bias and activated platelet components. Vox Sanguinis. 196-203.
Show author(s) (2004). Guidelines for transfusion in Norway. Transfusion and Apheresis Science. 181-184.

Editorial

Show author(s) (2022). Pure red cell aplasia after hematopoietic stem cell transplantation - experimental therapeutic approaches. Expert Opinion on Investigational Drugs. 881-884.

Show author(s) (2017). The blood donor with hemochromatosis: To be or not to be! Transfusion and Apheresis Science. 484-484.

Show author(s) (2010). Current debate on pathogen inactivation of platelet concentrates - To use or not to use? Transfusion and Apheresis Science. 411-414.

Show author(s) (2009). Does the preoperative iron status predict transfusion requirement of orthopedic patients? Transfusion and Apheresis Science. 213-217.

Reader opinion piece

Show author(s) (2010). Platelet transfusion in acute leukemia patients with severe chemotherapy-induced thrombocytopenia: the possible importance of hemoglobin levels and red blood cell transfusions for evaluation of clinical effects of transfusion. Transfusion. 2505-2506.
Show author(s) (2010). Inventory Management. Vox Sanguinis. e295-e363.

Short communication

Show author(s) (2018). Staff officers as blood suppliers: Effects of repeated donations and autologous reinfusions of untransfused units. Journal of Trauma and Acute Care Surgery. S89-S92.

Masters thesis

Show author(s) (2005). The functional quality of INTERCEPT – treated platelets during storage.